Prostate Cancer - Results from #26100

Impact of multiparametric endorectal coil prostate magnetic resonance imaging on disease reclassification among active surveillance candidates: A prospective cohort study - Abstract April 4, 2012

Androgen-deprivation therapy for nonmetastatic prostate cancer is associated with an increased risk of peripheral arterial disease and venous thromboembolism - Abstract April 4, 2012

Active surveillance versus surgery for low risk prostate cancer: A clinical decision analysis - Abstract April 4, 2012

Management of prostate cancer biochemical recurrence in the clinical guidelines - Abstract April 4, 2012

Hormone therapy for prostate cancer April 4, 2012

Epidemiology April 3, 2012

Prostate Cancer Natural History April 3, 2012

Using manual prostate contours to enhance deformable registration of endorectal MRI - Abstract April 3, 2012

The results of real-time brachytherapy for the management of low- and intermediate-risk prostate cancer in patients with prostate volumes up to 100 mL - Abstract April 3, 2012

Dietary factors and epigenetic regulation for prostate cancer prevention - Abstract April 3, 2012

Survival benefit during zoledronic acid and docetaxel-based chemotherapy in metastatic hormone-refractory prostate cancer patients: An institutional report - Abstract April 3, 2012

Compassionate use of abiraterone and cabazitaxel : First experiences in docetaxel-pretreated castration-resistant prostate cancer patients - Abstract April 3, 2012

Molecular markers as predictive factors biochemical failure after radical treatment of prostate cancer - Abstract April 3, 2012

Quality of life after biochemical recurrence in patients with prostate cancer. How and how long do patients live after biochemical recurrence? - Abstract April 3, 2012

Obesity-related systemic factors promote an invasive phenotype in prostate cancer cells - Abstract April 3, 2012

The clinical merit of anti-RANKL antibody denosumab in prostate cancer - Abstract April 3, 2012

Early clinical data show galeterone safe, effective against prostate cancer April 2, 2012

Metformin appeared to slow prostate cancer growth April 2, 2012

Oral vitamin D supplements reduced levels of Ki67 in prostate cancer cells April 2, 2012

Lack of oxygen influenced tumor behavior and patient outcome in intermediate-risk prostate cancer April 2, 2012

Page 1306 of 1437